Development and Validation of an Analytical Method for Determination of Modafinil in Bulk and Formulations using First Order Derivative UV Spectrophotometer

Authors

  • Hemal Tandel Assistant Professor
  • Dhaval Shah
  • Nilima Pandya
  • Amibkanandan Misra

DOI:

https://doi.org/10.37591/rrjodfdp.v6i3.655

Abstract

Analytical method validation is an important tool to determine the absolute concentration of drug in the formulation. In the case where a drug is not able to produce characteristic peak shape, a simple, accurate, precise and sensitive method, which will be governed through the software conversion of UV spectra into the first-order derivative, can be used as an alternative method for the estimation of modafinil in bulk and pharmaceutical dosage forms. Modafinil, estimated at 232 nm at which its first-order derivative curve gives a characteristic peak shape in ACN: water (35:65). The method was evaluated and found to be linear (obeys Beer’s law) in the defined concentration range of 2.5‑20 mcg/ml. According to ICH Q2 R1, the validation of the developed method was proceeded and was found to be accurate and precise. Thus, the proposed method can be successfully applied for the estimation of modafinil in relevant dosage forms.

 

Keywords: first-order derivative, ICH Q2 (R1) validation, linear regression value, Modafinil, spectrophotometer

 

Cite this Article

Hemal Tandel, Dhaval Shah, Nilima Pandya, Ambikanandan Misra. Development and Validation of an Analytical Method for Determination of Modafinil in Bulk and Formulations using First Order Derivative UV Spectrophotometer. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2019; 6(3): 23–29p.

Author Biography

  • Hemal Tandel, Assistant Professor
    Pharmacy

Downloads

Published

2019-12-26

Issue

Vol. 6 No. 3 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.